Integral Diagnostics Ltd
ASX:IDX
Wall Street
Price Targets
IDX Price Targets Summary
Integral Diagnostics Ltd
According to Wall Street analysts, the average 1-year price target for
IDX
is 3.5 AUD
with a low forecast of 3.23 AUD and a high forecast of 4.2 AUD.
Operating Income
Forecast
Operating Income Estimate
Integral Diagnostics Ltd
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's operating income is
17%.
The projected
CAGR
for the next 3 years is
30%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDX's stock price target?
Price Target
3.5
AUD
According to Wall Street analysts, the average 1-year price target for
IDX
is 3.5 AUD
with a low forecast of 3.23 AUD and a high forecast of 4.2 AUD.
What is Integral Diagnostics Ltd's Revenue forecast?
Projected CAGR
14%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's revenue is
24%.
The projected
CAGR
for the next 3 years is
14%.
What is Integral Diagnostics Ltd's Operating Income forecast?
Projected CAGR
30%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's operating income is
17%.
The projected
CAGR
for the next 3 years is
30%.
What is Integral Diagnostics Ltd's Net Income forecast?
Projected CAGR
147%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's net income is
-2%.
The projected
CAGR
for the next 3 years is
147%.
